FREMONT, Calif.--(BUSINESS WIRE)--WaferGen Bio-systems, Inc. (OTCBB: WGBS), a leading developer of state-of-the-art gene expression, genotyping, cell biology and stem cell research systems, announced that on Friday, March 27, it filed with the Securities and Exchange Commission its Annual Report on Form 10-K for the fiscal year ended December 31, 2008. Complete financial results for our 2008 fiscal year are contained in the 10-K, which can be accessed at www.sec.gov. The following summary of key accomplishments in 2008 and milestones for 2009 provides additional information about the Comnpany’s achievements and goals.
